300
Participants
Start Date
May 1, 2023
Primary Completion Date
April 1, 2024
Study Completion Date
July 31, 2025
Lansoprazole 15 mg
"1. Short-term treatment of active duodenal ulcer~2. Short-term treatment of active benign gastric ulcers~3. Thin heat of Helicobacter pylori to prevent recurrence of duodenal ulcer~4. Maintain duodenal ulcer after treatmentLaw~5. Treatment of nonsteroidal anti-inflammatory analgesics-induced gastric ulcers~6. Reducing the risk of developing nonsteroidal anti-inflammatory analgesic-induced gastric ulcers~7. Short-term treatment of gastroesophageal reflux disease~8. Short-term treatment of erosive reflux esophagitis~9. Post-treatment maintenance therapy for erosive reflux esophagitis~10. Pathological hyperdivision, including Zolinger Ellison syndrome"
Collaborators (1)
Jeil Pharmaceutical Co., Ltd.
INDUSTRY
Daejeon St. Mary's hospital
OTHER